Rezolute (RZLT) Share-based Compensation (2011 - 2026)
Rezolute's (RZLT) quarterly Share-based Compensation came in at $4.4 million in Q1 2026, up 132.02% year-on-year from $1.9 million in Q1 2025, and up 29.58% quarter-over-quarter from $3.4 million in Q4 2025.
Rezolute (RZLT) Share-based Compensation (2011 - 2026) Analysis & Trends
Rezolute has disclosed Share-based Compensation across 15 years of filings, most recently posting $4.4 million for Q1 2026.
- Share-based Compensation for Q1 2026 came in at $4.4 million, up 132.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.7 million (up 95.26% YoY), and the FY2025 annual result was $7.1 million, down 3.25% from the prior year.
- Share-based Compensation came in at $4.4 million for Q1 2026 at Rezolute, up from $3.4 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $4.4 million in Q1 2026 to a low of $100000.0 in Q2 2022.
- The 5-year median for Share-based Compensation is $1.8 million (2023), against an average of $1.9 million.
- Across the five-year window, Share-based Compensation tumbled 93.98% in 2022 and surged 1703.0% in 2023, its largest moves.
- Rezolute's Share-based Compensation stood at $1.7 million in 2022, then grew by 6.12% to $1.8 million in 2023, then retreated by 21.34% to $1.4 million in 2024, then surged by 136.06% to $3.4 million in 2025, then advanced by 29.58% to $4.4 million in 2026.
- The last three Share-based Compensation figures came in at $4.4 million (Q1 2026), $3.4 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Rezolute | 520.13 Mn | 520.13 Mn | - | 4.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.42 Mn |
| Mar 31, 2026 | 4.42 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Dec 31, 2025 | 3.41 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Sep 30, 2025 | 2.53 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.91 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Jun 30, 2024 | 1.77 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Mar 31, 2024 | 1.90 Mn |
| Dec 31, 2023 | 1.84 Mn |
| Dec 31, 2023 | 1.84 Mn |